A b s t r a c t . The s y n t h e s i s o f a c a r b o r a n y l n u c l e i c a c i d p r e c u r s o r 2 ' -0 -( 0 -c a r b o r a n -1 -y l r n e t h y l ) u r i d i n e , 1, and a c a r b o r a n y l n u c l e o t i d e , 8 , i s d e s c r i b e d . S i g n i f i c a n t l y g r e a t e r i n c o r p o r a t i o n and p e r s i s t e n c e o f 1 i n F 9 g g l i o m a c e l l s , compared w i t h t h e c l i n i c a l l y used Na2812HllSH i s observed.
compared w i t h t h e c l i n i c a l l y used Na2812HllSH i s observed.
The development o f boron compounds f o r t h e treatment o f cancer by boron neutron capture therapy (BNCT) i s based upon t h e nuclear f i s s i o n o f nonradioactive boron-10 atoms by thermal neutrons, generating h i g h l i n e a r energy t r a n s f e r (LET) p a r t i c l e s ( 1 ) . These have a destruct i v e range o f approximately 10 um. The b i o l o g i c a l e f f e c t i v e n e s o f BNCT i s g r e a t e r i f boron compounds are l o c a l i z e d i n t r a c e l l u l a r l y v i s -a -v i s on c e l l membrane o r i n e x t r a c e l l u l a r spaces. capture r e a c t i o n were t o occur i n the c e l l nucleus r a t h e r than i n t h e cytoplasm ( 2 ) . c l o s e r p r o x i m i t y o f t h e boron compound t o t h e tumor c e l l nucleus, t h e r e f o r e , t h e g r e a t e r i t s r a d i o b i o l o g i c a l e f f e c t . question? One o f t h e e a r l y approaches was t h e attempted synthesis o f boron heterocycles, which may be viewed as analogues o f t h e p u r i n e and p y r i m i d i n e bases o f t h e n a t u r a l l yo c c u r r i n g n u c l e i c acids (3-7). Many o f these, however, were h y d r o l y t i c a l l y unstable and/or f a i l e d t o mimic t h e bases as measured by c e l l u l a r i n c o r p o r a t i o n . One s t r u c t u r e which more c l o s e l y resembled these precursors was 5 -d i h y d r o x y b o r y l u r a c i l (8).
o f the f i r s t boron-containing p y r i m i d i n e nucleoside, 5-dihydroxyboryl-2I-deoxyuridine ( 9 ) . I n i t i a l b i o l o g i c a l studies i n d i c a t e d t h a t t h i s compound was a c o m p e t i t i v e i n h i b i t o r i n t h e phosphorylation o f thymidine ( l o ) , was nontoxic t o Vero ( A f r i c a n Green Monkey) c e l l s a t a concentration o f 1,600 IJM and appeared t o replace thymidine t o t h e e x t e n t o f 5-15% as determined by r a d i o b i o l o g i c a l studies w i t h V79 Chinese hamster c e l l s (11).
The nucleosides t h a t had been i n i t i a l l y prepared (9,12,13) contained a s i n g l e boron atom which was i n s e r t e d i n t o t h e p u r i n e o r p y r i m i d i n e base. Our o b j e c t i v e was t o i n c o r p o r a t e a carboranyl moiety i n t o t h e 2 ' -p o s i t i o n on t h e carbohydrate p o r t i o n o f t h e nucleoside.
The r a t i o n a l e was t h a t such s t r u c t u r e s would possess: (1) a t e n f o l d increase i n boron content compared w i t h t h e above boronic a c i d d e r i v a t i v e s ; ( 2 ) enhanced l i p o p h i l i c i t y f o r c e l l u l a r p e n e t r a t i o n due t o t h e carborane moiety; ( 3 ) p o s s i b l e c e l l u l a r entrapment and r e t e n t i o n p r o p e r t i e s i n p r o l i f e r a t i n g tumor c e l l s due t o t h e a c t i o n o f kinases; and ( 4 ) a r e t a i n e d c a p a c i t y when incorporated i n t o an o l i g o n u c l e o t i d e t o h y b r i d i z e s t r o n g l y w i t h
RNA and DNA sequences (14) since t h e base component would be n a t u r a l l y -o c c u r r i n g .
As t h e f i r s t s t r u c t u r e , we undertook t o synthesize 2'-O-(o-carboran-l-ylmethyl ) u r i d i n e , 1.
The method o f synthesis i n v o l v e d t h e i n i t i a l a l k y l a t i o n o f 2 ' ,3'-0-(dibutylstannylene)
u r i d i n e , 2, (15) w i t h 3-bromopropyne t o produce a m i x t u r e o f t h e a l k y l a t e d products, 2',(3')-0-(3-propynyl)uridine (3 and 4).
5:3 b u t attempts a t chromatographic separation were unsuccessful. was acetylated, t h e two isomers were r e a d i l y separated chromatographically on s i l i c a gel and t h e desired one, 3',5'-di-O-acety1-2'-0-(3-propynyl) u r i d i n e , 5 , was obtained i n 45% y i e l d from t h e t i n complex. Reaction o f 5 w i t h t h e bis(acetonitri1e)decaborane complex f u r n i s h e d t h e Corresponding carborane, 6 , which was q u a n t i t a t i v e l y deacetylated by c a t a l y t i c amounts,of sodium methoxide i n methanol t o y i e l d t h e desired t a r g e t compound 1 as shown by I K , H NMK and FAB mass spectrometry (16). Degradation o f t h e carborane cage t o t h e corresponding nido s t r u c t u r e , 7, was achieved by warming t o 40-45" i n methanolic p i p e r i d i n e ; the product obtained was t h e pTperidinium s a l t o f 1. the sodium s a l t o f 1 through i o n exchange chromatography o f t h i s p i p e r i d i n i u m s a l t .
version o f 1 t o a 5 ' -n u c l e o t i d e d e r i v a t i v e , 8, was obtained by use o f p-nitrophenylphosphorodichloridate i n p y r i d i n e l a c e t o n i t r i l e (17). phosphorylating agents have t h e c a p a c i t y f o r generating 5'-phospates w i t h o u t phosphorylating unprotected secondary a l c o h o l i c f u n c t i o n s i n t h e carbohydrate p o r t i o n o f t h e nucleoside (18). p-nitrophenyl masking group t o produce t h e f r e e n u c l e o t i d e i s planned. I t has been c a l c u l a t e d t h a t t h e e f f e c t w i l l be a t l e a s t t w i c e as g r e a t i f t h i s
The
How can such l o c a l i z a t i o n be achieved has been an ongoing This l e d t o t h e synthesis
The r a t i o o f 3 t o 4, as estimated by NMR, was However, when t h e m i x t u r e Work i s c u r r e n t l y underway t o prepare Con-
This and c e r t a i n o t h e r Compound 8 i s t h e f i r s t example o f a carboranylnucleotide and removal o f t h e A t present, l i t t l e i s known regarding t h e mechanisms f o r achieving s e l e c t i v e tumor c e l l i n c o r p o r a t i o n by various boron compounds. And, since t h e r e i s no i n f o r m a t i o n as t o how these new p o t e n t i a l n u c l e i c a c i d precursors w i l l be handled b i o l o g i c a l l y i n vivo, i t was o f i n t e r e s t t o determine t h e uptake and r e t e n t i o n o f these compounds i n v i t r o u s i n g v a r i o u s tumor c e l l l i n e s . i t would be reasonable t o c a r r y o u t i n v i v o d i s t r i b u t i o n s t u d i e s o f these nucleosides and nucleotides i n tumor-bearing animals.
A f t e r demonstrating uptake and persistence under such optimal conditions,
Development of carboranyl nucleic acid precursors
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The f i r s t compound which has been evaluated i n F98 glioma c e l l s i s 1. I n o r d e r t o demons t r a t e whether t h e r e was c e l l u l a r uptake and r e t e n t i o n , t h e f o l l o w i n g procedure was used. Semiconfluent F98 glioma c e l l s were incubated w i t h t h e compound f o r 16 hours and a f t e r two washings w i t h serum-free media, t h e c e l l s were t r y p s i n i z e d , washed t w i c e again and a l i q u o t s were analyzed f o r boron by D i r e c t Current Plasma (DCP) Atomic Emission Spectroscopy (19).
o f t h e carboranyluridine, 1, compared w i t h t h e c l i n i c a l l y -u s e d Na2B12Hl l SH. p a r t , may be due t o t h e g r e a t e r l i p o p h i l i c i t y o f 1 i n comparison with t h e mercaptopolyhedral borane anion.
The r e s u l t s , as shown i n Table 1 , demonstrate s i g n i f i c a n t l y g r e a t e r i n c o r p o r a t i o n This, i n O f g r e a t importance i s whether t h e compound once taken up i n t o t h e malignant c e l l , i s retained, regardless o f t h e biochemical mechanism involved, o r whether i t i s washed o u t i n t o t h e i n c u b a t i n g media? c e l l s which had demonstrated compound uptake were resuspended i n boron-free media and incubated f o r 12, 24, and 48 hrs. and these are a l s o presented i n Table 1 . I t i s apparent from these p r e l i m i n a r y r e s u l t s t h a t 1 p e r s i s t s f o r appreciable times once i t i s incorporated i n t o F98 glioma c e l l s and t h i s i s i n marked c o n t r a s t w i t h i\a2B12HllSH, which i s r a p i d l y removed, a t t a i n i n g background l e v e l s w i t h i n 6-12 hrs.
by which such r e t e n t i o n occurs and i n viva s t u d i e s now a r e planned i n order t o assess t h e p o t e n t i a l u t i l i t y o f 1 f o r BNCTT Also i n v i t r o studies w i t h 8 and t h e f r e e n u c l e o t i d e o f 2 w i l l be c a r r i e d o u t p r i o r t o any i n v i v o examination i n tumor-bearing animals.
I n order t o determine whether such c e l l u l a r persistence occurred, A l i q u o t s o f c e l l s were then analyzed f o r boron content I t remains t o be determined t h e p r e c i s e biochemical mechanism
